Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S.J. Dumas, F. Perros, C. Rücker-Martin, L. Tu, C. Guignabert, E. Gouadon, P. Dorfmüller, M. Humbert, S. Cohen-Kaminsky (Le Kremlin-Bicêtre, Châtenay-Malabry, Le Plessis-Robinson, Clamart, France). NMDA-type glutamate receptors contribute to the development of pulmonary hypertension. Eur Respir J 2012; 40: Suppl. 56, 4551

Member's Comments

No comment yet.

Related content which might interest you: LSC Abstract – Glutamatergic signaling through pulmonary vascular NMDA receptors in pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 NMDA receptor activation promotes vascular remodeling and pulmonary arterial hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond Source: Eur Respir J, 56 (2) 2001610; 10.1183/13993003.01610-2020 Year: 2020 Selective versus non-selective endothelin receptor antagonists Source: Annual Congress 2005 - New treatments in pulmonary hypertension Year: 2005 Overexpression of serotonin receptor 1B (5HT-1B) responsible for overflow induced experimental pulmonary arterial hypertension development Source: Annual Congress 2003 - Pathophysiology of the pulmonary circulation Year: 2003 Role of muscarinic receptors in airway inflammation and remodelling Source: International Congress 2015 – Respiratory research in the Netherlands Year: 2015 Is there a role for endothelin-1 receptor antagonists in the treatment of lung fibrosis associated with pulmonary hypertension? Source: Eur Respir J, 52 (2) 1801287; 10.1183/13993003.01287-2018 Year: 2018 Endothelin-a receptor antagonists reduce eNOS gene expression in rats with chronic hypoxic pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 271s Year: 2003 Endothelin receptor antagonists in pulmonary arterial hypertension Source: Eur Respir J 2008; 31: 407-415 Year: 2008 The endocannabinoids anandamide and 2-arachidonyl-glycerol (2-AG) induce pulmonary hypertension (PH) in a CB1 receptor independent manner - role of COX-2 and EP1 receptor activation Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005 The serotoninergic receptor subtype 5-HTR1B contributes to the pathogenesis of allergic airway inflammation Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats Source: Eur Respir J 2010; 35: 904-912 Year: 2010 NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD Source: Eur Respir J 2016; 47: 254-263 Year: 2016 Cholinergic muscarinic receptors and airway remodelling in severe asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Effects of AT1 receptor blockade on pulmonary and systemic manifestations in a COPD/emphysema mouse model Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009 Dual endothelin receptor antagonism: setting standards in PAH Source: Eur Respir Rev 2008; 17: 13-18 Year: 2007 NMDA receptor crosstalk with PDGFR-β and BMPR2 is involved in smooth muscle cell proliferation in pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension Source: Eur Respir J 2016; 48: 470-483 Year: 2016 NTP42, an antagonist of the thromboxane receptor, attenuates experimentally-induced pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 The role of purinergic P2X7 receptors on lipopolysaccharide (LPS)-induced lung injury Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight Year: 2007